Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States
Released December 5, 2001 and published on-line by the AIDS Treatment Information Service.

Table I. Pediatric AIDS Clinical Trials Group (PACTG) 076 Zidovudine (ZDV) Regimen
Table II. Preclinical and Clinical Data Relevant to the Use of Antiretrovirals in Pregnancy
Table III. Clinical Scenarios and Recommendations for the Use of Antiretroviral Drugs to Reduce Perinatal Human Immunodeficiency Virus (HIV) Transmission
Table IV. Comparison of Intrapartum/Postpartum Regimens for HIV-Infected Women in Labor Who Have Had No Prior Antiretroviral Therapy (Scenario 3)
Table V. Rate of perinatal transmission according to receipt of zidovudine during pregnancy and mode of delivery
Table VI. Clinical scenarios and recommendations regarding mode of delivery to reduce perinatal human immunodeficiency virus (HIV) transmission